ARCT vs COF · rev $152.3M vs P/E 62, rev $53.43B
Arcturus Therapeutics Holdings Inc (ARCT) versus Capital One Financial Corporation (COF) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Latest reported ARCT revenue for 2024-12-31 was $152.3M. Net income was -$80.9M. Revenue was down 8.7% from 2023-12-31 to 2024-12-31. ARCT currently screens at market cap $369.4M.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
ARCT currently screens at market cap $369.4M. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Not investment advice. Open the ARCT and COF stock pages for the full models.
Not investment advice.